Very interesting data - risk of increase in CV events not restricted to abiraterone - is a class effect with AR targeting, over and above the known risks with ADT alone
Throwing another one of my straw hats into the ring. Keen to promote @BSoT_UK & advocate for trainees across the UK
Your support would be warmly welcomed!
There is a documented risk of pun overload, although I am confident that communications will not go down the tubes…
🗳️✅
Wonderful news that our recent trainee Karthik Rajan has been awarded the @BSoT_UK#BronzeCystoscope. Really well deserved and all credit to him for being so supportive of his colleagues 👏
Congrats to our March IMPACT Award winners @AshwinUrol and Luke McGuinness! Their article “Management of Lymph Node–positive Penile Cancer: A Systematic Review” was the most influential work featured in our March 2024 issue!
Full article here: https://t.co/QVpLGFZ0k0
#UroSoMe
📢 What effect does the use of androgen receptor signalling inhibitors have on risk of falls & fractures in men with advanced #prostatecancer?
Amazing work @AshwinUrol and colleagues at @UoM_DCS and beyond, publishing in @EurUrolOncol
Grab a ☕and read: https://t.co/1fvT7DeedQ
This study found that women with breast cancer who used vaginal estrogen therapy (vaginal creams or vaginal tablets), compared with no hormone replacement therapy use, did not appear to have an increased risk of early breast cancer-specific mortality. https://t.co/XZ4bYUIlbB
Prescribe 2 years of abiraterone when offering radiotherapy to the prostate plus pelvis (for cN1) in combination with long-term ADT, for M0 patients with cN1 or ≥ 2 high-risk factors (cT3–4, Gleason ≥8 or PSA ≥40 ng/mL).
#ProstateCancer#EAUguidelines
https://t.co/0ax5QuNs6e
We cannot allow the ongoing issues around staffing gaps and poor morale to continue. Government breath holding like a toddler is unfair on patients. The DDRB needs putting back the way it was and a plan to fix pay.
Reducing caffeine intake may improve symptoms of urgency and frequency in women with overactive bladder (OAB), although it will not have an impact on incontinence.
#FemaleLUTS#EAUguidelines
https://t.co/6StQp4NMyE
Is your department ready for Urology Awareness Month? September is the month dedicated to urology, and we need your help to shine a spotlight on the causes and symptoms of urology disease. Send your request for a UAM resource pack to [email protected]#TUF#UAM23
Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy. #BeyondTheAbstract with @RathiNityam and @SCampbellMDPhD@CleClinicUro on UroToday > https://t.co/SgGuMBAXgh @SciReports